Nuria Labiod

498 total citations
17 papers, 280 citations indexed

About

Nuria Labiod is a scholar working on Infectious Diseases, Immunology and Animal Science and Zoology. According to data from OpenAlex, Nuria Labiod has authored 17 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 5 papers in Immunology and 3 papers in Animal Science and Zoology. Recurrent topics in Nuria Labiod's work include SARS-CoV-2 and COVID-19 Research (10 papers), Viral Infections and Vectors (4 papers) and COVID-19 Clinical Research Studies (4 papers). Nuria Labiod is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Viral Infections and Vectors (4 papers) and COVID-19 Clinical Research Studies (4 papers). Nuria Labiod collaborates with scholars based in Spain, France and Italy. Nuria Labiod's co-authors include Fátima Lasala, Rafaël Delgado, Joanna Luczkowiak, Corinne Vivès, Anna Bernardi, Franck Fieschi, Sara Sattin, Isabelle Bally, Daphna Fenel and Michel Thépaut and has published in prestigious journals such as The Journal of Infectious Diseases, Frontiers in Immunology and Emerging infectious diseases.

In The Last Decade

Nuria Labiod

17 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuria Labiod Spain 7 216 67 56 39 38 17 280
Megan C. Mears United States 6 244 1.1× 51 0.8× 101 1.8× 30 0.8× 32 0.8× 10 341
Jasmine Portmann Switzerland 7 151 0.7× 71 1.1× 67 1.2× 50 1.3× 25 0.7× 12 327
Brady T. Hickerson United States 10 265 1.2× 35 0.5× 37 0.7× 57 1.5× 69 1.8× 20 326
Yangchao Dong China 12 111 0.5× 39 0.6× 129 2.3× 15 0.4× 47 1.2× 23 291
Shanna Leventhal United States 10 298 1.4× 20 0.3× 46 0.8× 94 2.4× 114 3.0× 20 368
Qilin Xin China 10 228 1.1× 73 1.1× 106 1.9× 59 1.5× 150 3.9× 14 369
Jonas Fuchs Germany 9 165 0.8× 54 0.8× 54 1.0× 30 0.8× 53 1.4× 20 243
Sophia M. Reeder United States 5 160 0.7× 25 0.4× 68 1.2× 100 2.6× 130 3.4× 10 335
Bersabeh Tigabu United States 11 376 1.7× 74 1.1× 81 1.4× 45 1.2× 109 2.9× 18 487
Lawrence Mok Australia 7 225 1.0× 77 1.1× 71 1.3× 76 1.9× 45 1.2× 10 331

Countries citing papers authored by Nuria Labiod

Since Specialization
Citations

This map shows the geographic impact of Nuria Labiod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria Labiod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria Labiod more than expected).

Fields of papers citing papers by Nuria Labiod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria Labiod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria Labiod. The network helps show where Nuria Labiod may publish in the future.

Co-authorship network of co-authors of Nuria Labiod

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria Labiod. A scholar is included among the top collaborators of Nuria Labiod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria Labiod. Nuria Labiod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Labiod, Nuria, et al.. (2025). Oropouche Virus, A New Emerging Threat. Current Infectious Disease Reports. 27(1). 1 indexed citations
2.
3.
Belvisi, Laura, Nuria Labiod, Fátima Lasala, et al.. (2024). Unprecedented selectivity for homologous lectin targets: differential targeting of the viral receptors L-SIGN and DC-SIGN. Chemical Science. 15(37). 15352–15366. 4 indexed citations
4.
Lasala, Fátima, Nuria Labiod, Joanna Luczkowiak, et al.. (2023). MAFB shapes human monocyte–derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression. JCI Insight. 8(24). 3 indexed citations
5.
Nieto, Concha, Fátima Lasala, Nuria Labiod, et al.. (2023). TLR7 Activation in M-CSF-Dependent Monocyte-Derived Human Macrophages Potentiates Inflammatory Responses and Prompts Neutrophil Recruitment. Journal of Innate Immunity. 15(1). 517–530. 7 indexed citations
6.
Labiod, Nuria, et al.. (2023). The role of DC-SIGN as a trans-receptor in infection by MERS-CoV. Frontiers in Cellular and Infection Microbiology. 13. 1177270–1177270. 3 indexed citations
7.
Abdelnabi, Rana, Patricia Pérez, Hendrik Jan Thibaut, et al.. (2023). Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters. Frontiers in Immunology. 14. 1163159–1163159. 4 indexed citations
8.
Luczkowiak, Joanna, Nuria Labiod, Fátima Lasala, et al.. (2022). Cross neutralization of SARS‐CoV‐2 omicron subvariants after repeated doses of COVID‐19 mRNA vaccines. Journal of Medical Virology. 95(1). e28268–e28268. 6 indexed citations
9.
Goti, Giulio, Cinzia Colombo, Corinne Vivès, et al.. (2022). Precision Glycodendrimers for DC‐SIGN Targeting**. European Journal of Organic Chemistry. 2022(29). 5 indexed citations
10.
Almendro-Vázquez, Patricia, Alberto Utrero‐Rico, Rocío Laguna‐Goya, et al.. (2022). Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses. Frontiers in Immunology. 13. 981350–981350. 24 indexed citations
11.
Luczkowiak, Joanna, et al.. (2022). Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern. The Journal of Infectious Diseases. 227(1). 35–39. 3 indexed citations
12.
Thépaut, Michel, Joanna Luczkowiak, Corinne Vivès, et al.. (2021). DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS Pathogens. 17(5). e1009576–e1009576. 134 indexed citations
13.
Lasala, Fátima, Alfonso García‐Rubia, Inmaculada Galindo, et al.. (2021). Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses. Antiviral Research. 186. 105011–105011. 15 indexed citations
14.
Luczkowiak, Joanna, Nuria Labiod, Fátima Lasala, et al.. (2021). Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals. Open Forum Infectious Diseases. 8(10). ofab468–ofab468. 7 indexed citations
15.
Luczkowiak, Joanna, Nuria Labiod, Fátima Lasala, et al.. (2021). Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19–Convalescent Individuals. The Journal of Infectious Diseases. 225(11). 1905–1908. 10 indexed citations
16.
Herrero, Laura, María Paz Sánchez‐Seco, Nuria Labiod, et al.. (2020). Real-time RT-PCR assay to detect Granada virus and the related Massilia and Arrabida phleboviruses. Parasites & Vectors. 13(1). 270–270. 3 indexed citations
17.
Negredo, Anabel, M. Habela, Eva Ramírez de Arellano, et al.. (2019). Survey of Crimean-Congo Hemorrhagic Fever Enzootic Focus, Spain, 2011–2015. Emerging infectious diseases. 25(6). 1177–1184. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan C. Mears Breakdown of academic impact, for papers by Jasmine Portmann Breakdown of academic impact, for papers by Brady T. Hickerson Breakdown of academic impact, for papers by Yangchao Dong Breakdown of academic impact, for papers by Shanna Leventhal Breakdown of academic impact, for papers by Qilin Xin Breakdown of academic impact, for papers by Jonas Fuchs Breakdown of academic impact, for papers by Sophia M. Reeder Breakdown of academic impact, for papers by Bersabeh Tigabu Breakdown of academic impact, for papers by Lawrence Mok
Rankless by CCL
2026